Genius Sports Ltd. (NYSE:GENI) soared by 12.19 percent on Monday to finish at $7.27 apiece, as investors took heart from Goldman Sachs’ positive rating and price target upgrade for its stock.
In its coverage on the same day, the investment firm said it assigned a buy call on shares of Genius Sports Ltd. (NYSE:GENI), alongside a price target of $9.50, marking a 30 percent upside potential from its closing price.
According to Goldman, its coverage reflected its belief that Genius Sports Ltd. (NYSE:GENI) has a solid runway “to compound revenues at a mid-teens annual rate” over the next four years amid the secular tailwinds for the online sports betting market and the increasing contribution in non-betting areas such as media and advertising.
For illustration purposes only. Photo by Omar Ramadan on Pexels
2 More Analysts Update Coverage
Apart from Goldman Sachs, Genius Sports Ltd. (NYSE:GENI) also received mixed coverage from investment firms Stifel and Wells Fargo.
Stifel, for its part, issued a hold recommendation on the company while raising its price target to $7 from $5 previously—3.7 percent lower than its latest closing price.
Meanwhile, Wells Fargo recommended investors to buy the stock, but lowered its price target to $8 from $9 prior. Still, the figure represented a 10 percent upside potential.
Q2 Earnings
Based on its historical reporting dates, Genius Sports Ltd. (NYSE:GENI) is expected to announce the results of its earnings performance for the second quarter of the year on August 6, 2026.
For the period, the company is projected to report revenues of $185 million, or a 55.8 percent growth from the $118.7 million in the same period last year.
Adjusted EBITDA is also targeted at $45 million, or a 32 percent jump from the $34 million year-on-year.
The guidance includes the impact of its combination with Legend on May 1, 2026.
For the full-year period, Genius Sports Ltd. (NYSE:GENI) is targeting to grow its revenues by 48 percent to 50.8 percent to a range of $990 million to $1.01 billion.
Adjusted EBITDA is also projected to end at $270 million to $280 million, or a 98 to 106 percent jump from the $136 million year-on-year.
Hedge Fund Conviction Weakens
Institutional investors markedly softened for the company in the first quarter of the year.
Data from Insider Monkey showed that 37 hedge funds held positions during the period, down from 41 previously.
The combined value of their holdings also fell by 49 percent to $370.9 million from $726.8 million, signaling investor caution over competitive pressures and rising data rights costs, among others.
While we acknowledge the risk and potential of GENI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GENI and that has 10,000% upside potential, check out our report about the cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
